Truenat Molecular Diagnostics

Truenat® is a novel multi-disease real-time PCR platform. Designed to decentralize and expand access to accurate diagnostics with gold-standard molecular tests at the point of care, Truenat is fully automatic, battery-operated, and portable, making it ideal for diverse healthcare settings- from urban hospitals to remote health facilities.Patented in more than 100 countries, Truenat enables evidence-based treatment decisions for numerous infectious and non-communicable diseases such as tuberculosis, HIV, malaria, viral hepatitis, COVID-19, dengue, chikungunya, influenza, H1N1, HPV/cervical cancer, cholera, leprosy, etc. Fast to adapt to changing public health needs, the Truenat platform is a one-stop solution for disease outbreaks, enabling healthcare providers to be prepared and respond quickly to epidemics and pandemics. Truenat has been at the forefront of epidemics and disease outbreaks such as H1N1 in 2015, chikungunya in 2016, COVID-19 in 2020, and Nipah in 2021, ensuring early diagnosis and containment, thereby effectively cutting down the chain of transmission.